ITM Isotope Technologies Munich

ITM Isotope Technologies Munich

Private
Munich, BavariaHealthcare & Life Scienceshttps://www.itm-radiopharma.com

Last Round

Private Equity

6/6/2024

Total Funding Raised

$409.2M

Company Overview

ITM Isotope Technologies Munich is a radiopharmaceutical biotech company that provides medical radioisotopes, advanced targeted cancer diagnostics and therapies, and precision oncology technologies to enhance treatment outcomes for cancer patients.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Pharma Supply Chain, Precision Medicine, Drug Discovery

Business Model

B2B

Customer Profile

Hardware Sales, Services & Consulting

AI Layer

Non-AI

Keywords

global supply of medical radioisotopesno-carrier-added (n.c.a.) Lutetium-177 supplyvertically integrated radiopharmaceutical companyprecision oncology drug pipelinetargeted radionuclide therapy developmentActinium-225 supplyradiopharmaceutical active pharmaceutical ingredients (APIs)theranostics drug developmentautomated radiolabeling synthesizerradiopharmaceutical diagnostics

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

ITM Isotope Technologies Munich Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

ITM Isotope Technologies Munich Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
Private Equity6/6/2024
Early Funding6/6/2024

ITM Isotope Technologies Munich Investors

Notable investors and investment history

InvestorRounds
TemasekPrivate Equity, Early Funding
Athos KGPrivate Equity, Early Funding
Carbyne Equity PartnersPrivate Equity, Early Funding
BlackRockPrivate Equity, Early Funding
Qatar Investment AuthorityPrivate Equity, Early Funding

ITM Isotope Technologies Munich Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

ITM Isotope Technologies Munich Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about ITM Isotope Technologies Munich's valuation, stock price, and market status.

Firmographic Details

HeadquartersMunich, Bavaria
Employee Range632
Year Founded2004
Last Funding6/6/2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.







DisclaimerAll investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.